610 related articles for article (PubMed ID: 25960255)
1. Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.
Baudhuin LM; Lagerstedt SA; Klee EW; Fadra N; Oglesbee D; Ferber MJ
J Mol Diagn; 2015 Jul; 17(4):456-61. PubMed ID: 25960255
[TBL] [Abstract][Full Text] [Related]
2. Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants.
Beck TF; Mullikin JC; ; Biesecker LG
Clin Chem; 2016 Apr; 62(4):647-54. PubMed ID: 26847218
[TBL] [Abstract][Full Text] [Related]
3. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
Mu W; Lu HM; Chen J; Li S; Elliott AM
J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
[TBL] [Abstract][Full Text] [Related]
4. Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk.
Judkins T; Leclair B; Bowles K; Gutin N; Trost J; McCulloch J; Bhatnagar S; Murray A; Craft J; Wardell B; Bastian M; Mitchell J; Chen J; Tran T; Williams D; Potter J; Jammulapati S; Perry M; Morris B; Roa B; Timms K
BMC Cancer; 2015 Apr; 15():215. PubMed ID: 25886519
[TBL] [Abstract][Full Text] [Related]
5. Assessing the necessity of confirmatory testing for exome-sequencing results in a clinical molecular diagnostic laboratory.
Strom SP; Lee H; Das K; Vilain E; Nelson SF; Grody WW; Deignan JL
Genet Med; 2014 Jul; 16(7):510-5. PubMed ID: 24406459
[TBL] [Abstract][Full Text] [Related]
6. Confirmation of Insertion, Deletion, and Deletion-Insertion Variants Detected by Next-Generation Sequencing.
Choate LA; Koleilat A; Harris K; Vidal-Folch N; Guenzel A; Newman J; Peterson BJ; Peterson SE; Rice CS; Train LJ; Hasadsri L; Marcou CA; Moyer AM; Baudhuin LM
Clin Chem; 2023 Oct; 69(10):1155-1162. PubMed ID: 37566393
[TBL] [Abstract][Full Text] [Related]
7. A machine learning model to determine the accuracy of variant calls in capture-based next generation sequencing.
van den Akker J; Mishne G; Zimmer AD; Zhou AY
BMC Genomics; 2018 Apr; 19(1):263. PubMed ID: 29665779
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive assessment of Next-Generation Sequencing variants validation using a secondary technology.
Zheng J; Zhang H; Banerjee S; Li Y; Zhou J; Yang Q; Tan X; Han P; Fu Q; Cui X; Yuan Y; Zhang M; Shen R; Song H; Zhang X; Zhao L; Peng Z; Wang W; Yin Y
Mol Genet Genomic Med; 2019 Jul; 7(7):e00748. PubMed ID: 31165590
[TBL] [Abstract][Full Text] [Related]
9. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
[TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of the next-generation sequencing approach for molecular diagnosis of hereditary hearing loss.
Sivakumaran TA; Husami A; Kissell D; Zhang W; Keddache M; Black AP; Tinkle BT; Greinwald JH; Zhang K
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1007-16. PubMed ID: 23525850
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of an amplicon-based next-generation sequencing panel for detection of BRCA1 and BRCA2 genetic variants.
Shin S; Hwang IS; Lee ST; Choi JR
Breast Cancer Res Treat; 2016 Aug; 158(3):433-40. PubMed ID: 27383479
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the Calling Performance of a Rare Disease NGS Panel for Single Nucleotide and Copy Number Variants.
Cacheiro P; Ordóñez-Ugalde A; Quintáns B; Piñeiro-Hermida S; Amigo J; García-Murias M; Pascual-Pascual SI; Grandas F; Arpa J; Carracedo A; Sobrido MJ
Mol Diagn Ther; 2017 Jun; 21(3):303-313. PubMed ID: 28290094
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing using a pre-designed gene panel for the molecular diagnosis of congenital disorders in pediatric patients.
Lim EC; Brett M; Lai AH; Lee SP; Tan ES; Jamuar SS; Ng IS; Tan EC
Hum Genomics; 2015 Dec; 9():33. PubMed ID: 26666243
[TBL] [Abstract][Full Text] [Related]
14. Clinical investigational studies for validation of a next-generation sequencing in vitro diagnostic device for cystic fibrosis testing.
Grosu DS; Hague L; Chelliserry M; Kruglyak KM; Lenta R; Klotzle B; San J; Goldstein WM; Moturi S; Devers P; Woolworth J; Peters E; Elashoff B; Stoerker J; Wolff DJ; Friedman KJ; Highsmith WE; Lin E; Ong FS
Expert Rev Mol Diagn; 2014 Jun; 14(5):605-22. PubMed ID: 24844137
[TBL] [Abstract][Full Text] [Related]
15. Software-Assisted Manual Review of Clinical Next-Generation Sequencing Data: An Alternative to Routine Sanger Sequencing Confirmation with Equivalent Results in >15,000 Germline DNA Screens.
Muzzey D; Kash S; Johnson JI; Melroy LM; Kaleta P; Pierce KA; Ready K; Kang HP; Haas KR
J Mol Diagn; 2019 Mar; 21(2):296-306. PubMed ID: 30529126
[TBL] [Abstract][Full Text] [Related]
16. Analysis of pathogenic variants from the ClinVar database in healthy people using next-generation sequencing.
Rančelis T; Arasimavičius J; Ambrozaitytė L; Kavaliauskienė I; Domarkienė I; Karčiauskaitė D; Kučinskienė ZA; Kučinskas V
Genet Res (Camb); 2017 Aug; 99():e6. PubMed ID: 28851476
[TBL] [Abstract][Full Text] [Related]
17. Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics.
Sikkema-Raddatz B; Johansson LF; de Boer EN; Almomani R; Boven LG; van den Berg MP; van Spaendonck-Zwarts KY; van Tintelen JP; Sijmons RH; Jongbloed JD; Sinke RJ
Hum Mutat; 2013 Jul; 34(7):1035-42. PubMed ID: 23568810
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing (NGS) in the microbiological world: How to make the most of your money.
Vincent AT; Derome N; Boyle B; Culley AI; Charette SJ
J Microbiol Methods; 2017 Jul; 138():60-71. PubMed ID: 26995332
[TBL] [Abstract][Full Text] [Related]
19. ClinQC: a tool for quality control and cleaning of Sanger and NGS data in clinical research.
Pandey RV; Pabinger S; Kriegner A; Weinhäusel A
BMC Bioinformatics; 2016 Feb; 17():56. PubMed ID: 26830926
[TBL] [Abstract][Full Text] [Related]
20. Performance evaluation of an amplicon-based next-generation sequencing panel for BRCA1 and BRCA2 variant detection.
Park K; Kim MK; Lee T; Hong J; Kim HK; Ahn S; Lee YJ; Kim J; Lee SW; Lee JW; Lee W; Chun S; Son BH; Jung KH; Kim YM; Min WK; Ahn SH
J Clin Lab Anal; 2020 Dec; 34(12):e23524. PubMed ID: 32812259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
